| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ... The Journal of urology 199 (3), 683-690, 2018 | 1202* | 2018 |
| Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases … DV Makarov, BJ Trock, EB Humphreys, LA Mangold, PC Walsh, JI Epstein, ... Urology 69 (6), 1095-1101, 2007 | 664 | 2007 |
| Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial LS Marks, NA Mazer, E Mostaghel, DL Hess, FJ Dorey, JI Epstein, ... Jama 296 (19), 2351-2361, 2006 | 530 | 2006 |
| Biomarkers for prostate cancer DV Makarov, S Loeb, RH Getzenberg, AW Partin Annual review of medicine 60 (1), 139-151, 2009 | 258 | 2009 |
| Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression H Samaratunga, DV Makarov, JI Epstein Urology 60 (2), 315-319, 2002 | 166 | 2002 |
| Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy HS Park, CP Gross, DV Makarov, BY James International Journal of Radiation Oncology* Biology* Physics 83 (5), 1365-1373, 2012 | 165 | 2012 |
| Surgical decompression is associated with decreased mortality in patients with sepsis and ureteral calculi MS Borofsky, D Walter, O Shah, DS Goldfarb, AC Mues, DV Makarov The Journal of urology 189 (3), 946-951, 2013 | 149 | 2013 |
| Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 3 and 3 4 independent of the number of involved cores? DV Makarov, H Sanderson, AW Partin, JI Epstein The Journal of urology 167 (6), 2440-2442, 2002 | 137 | 2002 |
| How active is active surveillance? Intensity of followup during active surveillance for prostate cancer in the United States S Loeb, D Walter, C Curnyn, HT Gold, H Lepor, DV Makarov The Journal of urology 196 (3), 721-726, 2016 | 114 | 2016 |
| Five-year nationwide follow-up study of active surveillance for prostate cancer S Loeb, Y Folkvaljon, DV Makarov, O Bratt, A Bill-Axelson, P Stattin European urology 67 (2), 233-238, 2015 | 109 | 2015 |
| The RoboConsultant: telementoring and remote presence in the operating room during minimally invasive urologic surgeries using a novel mobile robotic interface R Agarwal, AW Levinson, M Allaf, DV Makarov, A Nason, LM Su Urology 70 (5), 970-974, 2007 | 108 | 2007 |
| Clinically localized prostate cancer: AUA/ASTRO/SUO guideline MG Sanda, RC Chen, T Crispino, S Freedland, K Greene, LH Klotz, ... Risk 6, 27, 2017 | 97 | 2017 |
| The association between diffusion of the surgical robot and radical prostatectomy rates DV Makarov, BY James, RA Desai, DF Penson, CP Gross Medical care 49 (4), 333-339, 2011 | 96 | 2011 |
| Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer O Bratt, Y Folkvaljon, MH Eriksson, O Akre, S Carlsson, L Drevin, ... European urology 68 (1), 53-58, 2015 | 92 | 2015 |
| The effect of ureteral stent placement on post-ureteroscopy complications: a meta-analysis DV Makarov, BJ Trock, ME Allaf, BR Matlaga Urology 71 (5), 796-800, 2008 | 91 | 2008 |
| The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy DV Makarov, EB Humphreys, LA Mangold, MA Carducci, AW Partin, ... The Journal of urology 179 (1), 156-162, 2008 | 86 | 2008 |
| Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US MR Cooperberg, W Meeks, R Fang, FD Gaylis, WJ Catalona, DV Makarov JAMA network open 6 (3), e231439-e231439, 2023 | 83 | 2023 |
| The cost implications of prostate cancer screening in the Medicare population X Ma, R Wang, JB Long, JS Ross, PR Soulos, JB Yu, DV Makarov, ... Cancer 120 (1), 96-102, 2014 | 81 | 2014 |
| Robotic surgery claims on United States hospital websites LX Jin, AM Ibrahim, NA Newman, DV Makarov, PJ Pronovost, MA Makary The Journal for Healthcare Quality (JHQ) 33 (6), 48-52, 2011 | 81 | 2011 |
| p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape S Isharwal, MC Miller, C Marlow, DV Makarov, AW Partin, RW Veltri The Prostate 68 (10), 1097-1104, 2008 | 80 | 2008 |
Alan W. PartinJohns HopkinsOverená e-mailová adresa na: jhmi.edu
